Live Cell Imaging Market Regional Analysis

Robust investments in medical R&D and supportive government initiatives allow North America to account for a dominant share of the global live cell imaging market. Rising cell research activity in the region, increasing oncology research, and growing demand for cell therapies are also expected to favor the demand for live cell imaging in this region. The United States is projected to spearhead revenue generation in this region followed by Canada. Moreover, the presence of a developed healthcare infrastructure also opens new avenues of opportunities for live cell imaging companies.

Europe is predicted to account for the second-largest share of the global live cell imaging market. Surging prevalence of chronic diseases coupled with high investments in medical R&D are projected to bolster the demand for live cell imaging in this region. The United Kingdom, France, and Germany are slated to be the most opportune markets for live cell imaging providers in this region. Supportive funding from private and government institutions to advance cell research will also bolster the demand for live cell imaging in Europe over the coming years.